Evidence map›Paper›PMID 24274902›Full record

ArticleChemical research in toxicology2014

Cross-linking of thioredoxin reductase by the sulfur mustard analogue mechlorethamine (methylbis(2-chloroethyl)amine) in human lung epithelial cells and rat lung: selective inhibition of disulfide reduction but not redox cycling.

Yi-Hua Jan, Diane E Heck, Rama Malaviya, Robert P Casillas, Debra L Laskin, Jeffrey D Laskin

Abstract read
In one paragraph

Article in Chemical research in toxicology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Sulfa drugs inhibit sepiapterin reduction and chemical redox cycling by sepiapterin reductase.The Journal of pharmacology and experimental therapeutics · 2015
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Yi-Hua JanDepartment of Environmental and Occupational Medicine, Rutgers University-Robert Wood Johnson Medical School , Piscataway, New Jersey 08854, United States.
Diane E Heck
Rama Malaviya
Robert P Casillas
Debra L Laskin
Jeffrey D Laskin
Rutgers, The State University of New Jersey · USJohnson University · USMRIGlobal · USNew York Medical College · US

Funding

UMDNJ/Rutgers University CounterACT Research Center of ExcellenceU54AR055073 · NIAMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI HECK, DIANE E · 2006 to 2024
$71.4M
Translational Research Support CoreP30ES005022 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI HELMUT ZARBL · 1988 to 2026
$47.4M
ACTIVATED MACROPHAGES AND OZONE TOXICITYR01ES004738 · NIEHS · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI Debra L Laskin · 1989 to 2026
$9.0M
ROLE OF KUPFFER CELLS IN CHEMICAL TOXICITYR01GM034310 · NIGMS · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI LASKIN, DEBRA L · 1985 to 2009
$3.1M
Macrophages and Inflammatory Mediators in Silica-Induced CarcinogenesisR01CA132624 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI LASKIN, DEBRA L · 2008 to 2012
$1.5M
Mechanisms of Sulfur Mustard ToxicologyF32ES017389 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI JAN, YIHUA · 2009 to 2010
$111k
NCI NIH HHS CA132624NCI NIH HHS R01 CA132624NIAMS NIH HHS AR055073NIAMS NIH HHS U54 AR055073NIAMS NIH HHS U54AR055073NIEHS NIH HHS ES004738NIEHS NIH HHS ES005022NIEHS NIH HHS F32 ES017389NIEHS NIH HHS F32ES017389NIEHS NIH HHS P30 ES005022NIEHS NIH HHS R01 ES004738NIGMS NIH HHS GM034310NIGMS NIH HHS R01 GM034310
6 · The paper itself

Abstract

Oxidative stress plays a key role in mechlorethamine (methylbis(2-chloroethyl)amine, HN2) toxicity. The thioredoxin system, consisting of thioredoxin reductase (TrxR), thioredoxin, and NADPH, is important in redox regulation and protection against oxidative stress. HN2 contains two electrophilic side chains that can react with nucleophilic sites in proteins, leading to changes in their structure and function. We report that HN2 inhibits the cytosolic (TrxR1) and mitochondrial (TrxR2) forms of TrxR in A549 lung epithelial cells. TrxR exists as homodimers under native conditions; monomers can be detected by denaturing and reducing SDS-PAGE followed by western blotting. HN2 treatment caused marked decreases in TrxR1 and TrxR2 monomers along with increases in dimers and oligomers under reducing conditions, indicating that HN2 cross-links TrxR. Cross-links were also observed in rat lung after HN2 treatment. Using purified TrxR1, NADPH reduced, but not oxidized, enzyme was inhibited and cross-linked by HN2. LC-MS/MS analysis of TrxR1 demonstrated that HN2 adducted cysteine- and selenocysteine-containing redox centers forming monoadducts, intramolecule and intermolecule cross-links, resulting in enzyme inhibition. HN2 cross-links two dimeric subunits through intermolecular binding to cysteine 59 in one subunit of the dimer and selenocysteine 498 in the other subunit, confirming the close proximity of the N- and C-terminal redox centers of adjacent subunits. Despite cross-linking and inhibition of TrxR activity by HN2, TrxR continued to mediate menadione redox cycling and generated reactive oxygen species. These data suggest that disruption of the thioredoxin system contributes to oxidative stress and tissue injury induced by HN2.

Indexed as

AnimalsCells, CulturedCross-Linking ReagentsDisulfidesEpithelial CellsHumansLungMaleMechlorethamineModels, MolecularOxidation-ReductionRatsRats, WistarThioredoxin-Disulfide ReductaseCross-Linking ReagentsDisulfidesMechlorethamineThioredoxin-Disulfide Reductase

Identifiers

PMID24274902
PMCPMC4070429
OpenAlexW2003286375

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.